
Common deficiencies of CMC dossiers for new drug applications of autologous CAR-T cell therapy medicinal products and key points to consider in review process
HAN Dong-mei, CUI Jing, WEI Wei
Common deficiencies of CMC dossiers for new drug applications of autologous CAR-T cell therapy medicinal products and key points to consider in review process
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |